Publications & Grants


  • Image Analysis Method for Evaluating Heterogeneous Growth and Differentiation of Embryonic Stem Cell Cultures. Hunt, MM., Meng, G., Rancourt, DE., Gates, ID., Kallos, MS. Best of BIOT award, American Chemical Society, Division of Biochemical Technology, eBook Chapter 10 in Developments in Biotechnology and Bioprocessing. 2013, American Chemical Society. p. 165-181. Chapter DOI: 10.1021/bk-2013-1125.ch010, ACS Symposium Series, Vol. 1125, ISBN13: 9780841229105 eISBN: 9780841229112, Publication Date (Web): March 8, 2013
  • Bioreactor Expansion of Skin Derived Precursor Schwann Cells. Walsh, T, Biernaskie, J, Midha, R, Kallos, MS., Methods in Molecular Biology (2016), Human Press, DOI: 10.1007/7651_2016_355
  • 2022-2024: Developmental origins of vertebral deformities – defining the critical role of the NOTCH signaling pathway. ACHRI Grand Challenge Catalyst – Seedling award. (2 Years; $50,000). PI: Jack Chu. Co-PIs: Alex Lohman, Mark Ungrin.

  • 2021-2023: Establishing a cervid stem cell-derived infection model for chronic wasting disease prions. New Frontiers in Research Fund – Exploration. (2 Years; $200,000). PI: Sabine Gilch. Co-PI: Jack Chu. Co-Applicant: Rob McCorkell.

  • 2021-2023: Developmental origins of congenital heart disease - defining the critical role of the placenta. ACHRI Grand Challenge Catalyst – Branch award. (2 Years; $200,000). PI: Myriam Hemberger. Co-PIs: Wendy Dean, Antoine Dufour, Mike Kallos, Mark Ungrin, Jack Chu.

  • 2021: Centre for Cell Therapy Translation (C2T2). Canadian Foundation for Innovation – Infrastructure fund (5 years; $4,579,508). PIs: Jeff Biernaskie, Mike Kallos. Co-Applicants: Roman Krawetz, Ina Dobrinski, Derrick Rancourt, Vince Gabriel, Paul Fedak, Holly Sparks, Mark Ungrin.

  • 2021: Role for Lipid Droplet Associated IL-32 in Diabetic Kidney Disease. Canadian Institute of Health Research (CIHR) Project Grant ($715,275). PI: Justin Chun. Collaborator: Jeff Biernaskie.

  • 2020-2025: Transplantation of Testis Stem Cells in Large Animals. NIH/ORIP. ($ 1,024,525). PI: Ina Dobrinski. Collaborators: Mark Ungrin, Claudia Klein.

  • 2018-2023: Understanding dermal progenitor biology towards improved skin wound healing. CIHR Project Grant (5 Years, $749,700). PI: Jeff Biernaskie. Co-Applicant: Vince Gabriel.

  • 2018-2023: Understanding Schwann cell heterogeneity for improved nerve repair. CIHR Project Grant (5 Years; $1,077,120). PI: Rajiv Midha. Co-Investigator: Jeff Biernaskie.

  • 2017-2022: A system for culturing mammalian spermatogonial cells. NIH/NICHD ($ 702,880). PI: Ina Dobrinski. Collaborators: Mark Ungrin, Derrick Rancourt, Mike Kallos.

  • 2016-2019: Derivation and Culture of Naïve Pluripotent Stem Cells in Stirred Suspension Bioreactors. CIHR ($ 351,690). PI: Derrick Rancourt. Co-PI: Mike Kallos.

  • 2016-2019: Derivation and Culture of Naïve Pluripotent Stem Cells in Stirred Suspension Bioreactors. Natural Science and Engineering Research Council. ($ 351,689). PI: Derrick Rancourt. Co-PI: Mike Kallos.

  • A bioprocess that optimizes safe Human iPSCs for the treatment of osteoporotic fractures. CIHR/IMHA. ($100,000). PI: Roman Krawetz. Co-PI: Mike Kallos.

  • A bioprocess that optimizes safe Human iPSCs for the treatment of osteoporotic fractures. CIHR. ($695,000). PI: Roman Krawetz. Co-PI: Mike Kallos.